Cisplatin neuropathy: clinical course and neurophysiological findings

Summary Sixteen patients treated with cisplatin (CDDP) 40 mg/m² on days 1–5 every 4 weeks for three courses (cumulative dose 600 mg/m²) were clinically and neurophysiologically tested before, during and 1, 3, 6, 9 and 12 months after CDDP administration. The first symptoms of polyneuropathy occurred in 4 of 9 patients after the second course (cumulative dose 400 mg/m²). One month after treatment 1 of 9 patients was asymptomatic, 5 complained of symptoms and 3 showed clinical and neurophysiological signs of polyneuropathy. Three months after CDDP all patients were affected. Clinical and neurophysiological signs of severity progression were noted up to 6 months after treatment with CDDP.